Locust Walk Partners has launched as a strategic and transactional advisory firm for the life sciences market. It has offices in Boston and Philadelphia, and is led by industry vets Geoff Meyerson and Jay Mohr.
Locust Walk Partners (LWP) announced today the formation of its boutique strategic and transaction advisory firm. LWP provides strategic reviews and business and corporate development execution for biopharmaceutical, medical device, and diagnostics companies to help leverage their resources, maximize the value of their assets and, ultimately, shareholder returns.
Led by co-founding Managing Directors Geoff Meyerson and Jay Mohr, LWP brings deep strategic and commercial insight plus a deal track record including buy- and sell-side licensing, mergers and acquisitions, and private and public fundraising. Added to this expertise is a group of seasoned team members and advisors with business and corporate development capabilities and operating, scientific, regulatory, intellectual property, and technology transfer competencies.
“Locust Walk Partners fills a void in the market, providing services not offered by management consulting firms or investment banks,” explains Jay Mohr. “Companies need to determine the role of pipeline assets, position them appropriately in the marketplace, and execute a transaction yielding significant value.” Adds Geoff Meyerson, “In today’s financial climate, companies want access to strategic advice and business and corporate development expertise in a capital efficient, success driven manner.”
Mr. Meyerson has significant transaction experience from roles in investment banking, venture capital, and business development. He has worked for UBS Investment Bank, SROne, MedImmune, and Zelos Therapeutics. Mr. Meyerson holds a BS from Duke University, a Masters in Biotechnology from the University of Pennsylvania, and an MBA from The Wharton School. Mr. Mohr has nearly 20 years of commercial, operating, business development and company formation/fundraising experience in emerging and established biopharmaceutical companies. He has held senior management positions at Schering-Plough and Serono and C-level roles at Variagenics/Nuvelo, Gloucester Pharmaceuticals, and Zelos. He holds a BA from Vanderbilt University and an MBA from The Wharton School.
About Locust Walk Partners
Locust Walk Partners is a strategic and transaction advisory firm that provides strategic reviews, asset positioning and deal execution to life science companies. The team applies considerable operational, business development, commercial, venture capital, and investment banking experience to help clients maximize capital efficiency and financial returns. Services include licensing transactions, mergers and acquisitions, and strategic assessments. Locust Walk Partners is located in Boston and Philadelphia.